Sheldon Weinbaum Selected Research

A-factor (Streptomyces)

3/2014	Effect of tissue properties, shape and orientation of microcalcifications on vulnerable cap stability using different hyperelastic constitutive models.
3/2008	Micro-CT based analysis of a new paradigm for vulnerable plaque rupture: cellular microcalcifications in fibrous caps.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheldon Weinbaum Research Topics

Disease

7	Calcinosis 01/2021 - 03/2008
5	Rupture 01/2021 - 03/2010
5	Atherosclerotic Plaque (Atheroma) 01/2020 - 02/2014
2	Hyperglycemia 01/2020 - 04/2007
1	Vascular Calcification 01/2021
1	Atherosclerosis 01/2021
1	Inflammation (Inflammations) 01/2020
1	Bone Resorption 06/2013
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2005
1	Herpes Zoster 02/2003

Drug/Important Bio-Agent (IBA)

3	Apolipoproteins E (ApoE)IBA 01/2021 - 03/2010
3	ElementsIBA 01/2021 - 02/2014
2	HydrogelsIBA 01/2021 - 03/2016
2	MineralsIBA 01/2021 - 03/2016
2	CollagenIBA 01/2021 - 03/2016
2	LipidsIBA 06/2015 - 02/2014
2	A-factor (Streptomyces)IBA 03/2014 - 03/2008
2	Explosive Agents (Explosives)IBA 02/2014 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 11/2005 - 02/2003
1	Ibandronic Acid (Boniva)FDA Link 01/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Lipid NanoparticlesIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Biological ProductsIBA 06/2013
1	ApolipoproteinsIBA 03/2010
1	DiureticsIBA 04/2007
1	AcidsIBA 11/2005
1	SodiumIBA 11/2005
1	PotassiumIBA 11/2005
1	ConnexinsIBA 02/2003

Therapy/Procedure

1	Therapeutics 01/2021